Bonesupport Holding AB (publ) (STO:BONEX)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	1.17B	898.73M	591.08M	328.82M	212.89M
Total	1.17B	898.73M	591.08M	328.82M	212.89M

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	971.91M	715.94M	442.40M	216.90M	121.70M
Sweden	12.60M	10.80M	11.60M	9.70M	7.90M
Other Europe & Rest of The World	94.85M	82.98M	63.63M	53.64M	45.23M
United Kingdom	95.30M	89.00M	73.40M	48.60M	38.10M
North America Excl. USA	-	-	49.00K	-24.00K	-43.00K
Total	1.17B	898.73M	591.08M	328.82M	212.89M

Data Source: S&P Global Market Intelligence Last updated: Jul 16, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error